Chimeric Therapeutics Limited (CHM.AX)
AUD 0.01
(25.0%)
AUD 0.01
(25.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -12.3 Million AUD | 58.25% |
| 2023 | -29.48 Million AUD | -113.4% |
| 2022 | -13.81 Million AUD | 8.54% |
| 2021 | -15.1 Million AUD | -23502.3% |
| 2020 | -64.01 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -7.48 Million AUD | 18.79% |
| 2024 FY | -20.71 Million AUD | 29.73% |
| 2024 Q2 | -9.21 Million AUD | -1148.65% |
| 2024 Q1 | 878.58 Thousand AUD | 105.92% |
| 2024 Q4 | -16.77 Million AUD | -53.78% |
| 2023 Q1 | -5.82 Million AUD | 25.75% |
| 2023 Q2 | -14.65 Million AUD | -151.68% |
| 2023 Q4 | -14.82 Million AUD | -122.44% |
| 2023 Q3 | -6.66 Million AUD | 54.52% |
| 2023 FY | -29.48 Million AUD | -113.4% |
| 2022 Q4 | -7.84 Million AUD | -211.98% |
| 2022 Q3 | -2.51 Million AUD | 73.1% |
| 2022 Q2 | -9.34 Million AUD | -95.84% |
| 2022 Q1 | -4.77 Million AUD | 57.79% |
| 2022 FY | -13.81 Million AUD | 8.54% |
| 2021 Q4 | -11.3 Million AUD | -101.08% |
| 2021 FY | -15.1 Million AUD | -23502.3% |
| 2021 Q3 | -5.62 Million AUD | -58.69% |
| 2021 Q1 | -1.8 Million AUD | 0.0% |
| 2021 Q2 | -3.54 Million AUD | -96.64% |
| 2020 FY | -64.01 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acrux Limited | -9.83 Million AUD | -25.175% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 72.523% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 125.046% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 105.448% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 73.926% |
| AdAlta Limited | -5.26 Million AUD | -133.953% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 37.201% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 16.26% |
| BTC Health Limited | 1.05 Million AUD | 1266.477% |
| CSL Limited | 5.64 Billion AUD | 100.218% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 226.688% |
| Hexima Limited | -1 Million AUD | -1120.29% |
| Immutep Limited | -44.93 Million AUD | 72.607% |
| Memphasys Limited | -2.7 Million AUD | -355.239% |
| Noxopharm Limited | -7.53 Million AUD | -63.367% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -71.291% |
| Race Oncology Limited | -13.38 Million AUD | 8.003% |
| Starpharma Holdings Limited | -15.15 Million AUD | 18.796% |
| Tissue Repair Ltd | -4.87 Million AUD | -152.457% |
| Biotron Limited | -5.15 Million AUD | -138.969% |
| Biome Australia Limited | -1.91 Million AUD | -543.394% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -743.633% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -301.953% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -107.295% |
| Patrys Limited | -3.53 Million AUD | -247.814% |
| Orthocell Limited | -11.68 Million AUD | -5.381% |
| Imugene Limited | -140.93 Million AUD | 91.265% |
| PYC Therapeutics Limited | -38.85 Million AUD | 68.321% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -70.222% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -39.757% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -71.133% |
| Nanollose Limited | -1.24 Million AUD | -884.912% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -476.937% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -498.557% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -178.187% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -328.344% |
| Nyrada Inc. | -4.56 Million AUD | -169.93% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 50.879% |
| PharmAust Limited | -6.65 Million AUD | -84.868% |
| AnteoTech Limited | -11.72 Million AUD | -4.972% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 81.095% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 44.177% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -168.232% |
| Actinogen Medical Limited | -12.83 Million AUD | 4.123% |
| Immuron Limited | -5.8 Million AUD | -112.195% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -117.056% |